STOCK TITAN
  1. Home
  2. News
  3. ESTA

Establishment Labs Announces Participation in the UBS Global Healthcare Virtual Conference

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced that CEO and Founder Juan José Chacón-Quirós and Chief Financial Officer Renee Gaeta will participate in the UBS Global Healthcare Virtual Conference, which is being held May 24-26, 2021. Mr. Chacón-Quirós and Mrs. Gaeta are scheduled to speak to conference attendees at 9:00 am ET on Monday, May 24, 2021.

A live webcast of the presentation will be available to all interested parties on the Establishment Labs investor relations website at https://investors.establishmentlabs.com/. An archived version of the webcast will be available on the same website following the completion of the event.

About Establishment Labs

Establishment Labs Holdings Inc. (NASDAQ: ESTA) is a global medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, by designing, developing, manufacturing and marketing an innovative portfolio of silicone gel-filled breast implants, branded as Motiva Implants®, the centerpiece of the MotivaImagine® platform. Motiva Implants® are produced at our two manufacturing sites that are compliant with ISO13485:2016, FDA 21 CFR 820 under the MDSAP program, and are currently commercially available in more than 80 countries through exclusive distributors or the Company’s direct salesforce. In March 2018, Establishment Labs received approval for an investigational device exemption (IDE) from the FDA and initiated the Motiva Implant® clinical trial in the United States in April 2018. In addition to Motiva Implants®, Establishment Labs’ product and technologies portfolio includes the Divina® 3D Simulation System and other products and services. Please visit our website for additional information at www.establishmentlabs.com.

Stock ESTA logo
Establishment Labs Holdings Inc.

NASDAQ:ESTA

ESTA Rankings

#2129 Ranked by Market Cap
#4482 Ranked by Stock Gains
N/A Ranked by Dividends

ESTA Latest News

May 8, 2024
Establishment Labs Reports First Quarter 2024 Financial Results
May 2, 2024
Establishment Labs Notes Presentation of 4-Year Results from Motiva U.S. IDE Study at The Aesthetic Meeting 2024
May 1, 2024
Establishment Labs Announces Appointment of Jeff Ehrhardt as General Manager of North America
Apr 24, 2024
Establishment Labs to Announce First Quarter 2024 Financial Results on May 8
Apr 17, 2024
Establishment Labs Announces Participation in The Aesthetic Meeting 2024

ESTA Stock Data

1.56B
16.31M
12.45%
75.8%
18.1%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
ALAJUELA

About ESTA

establishment labs is a global, privately held, high-tech medical device and aesthetics company that designs, develops, manufactures and markets an innovative product portfolio consisting of advanced silicone-filled breast and body shaping implants. with more than 30 years of advanced breast implant manufacturing experience, building quality breast implants has always been a natural outcome for establishment labs’ founders and top executives. as a result, motiva implants® has established a level of product innovation that always results in safety. and while we respect our past, we ́re more focused on the present and the future, one that ́s innovative, safe and progressive. we believe that these goals can be achieved by incorporating the current needs and preferences of plastic surgeons and patients into our product design.